3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Tinnitus, Subjective: new trials by email Literature Review of Tinnitus, Subjective trials Research Report on Tinnitus, Subjective
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OTO-313 in Subjects With Subjective Tinnitus OTO-313, Placebo - Tinnitus, Subjective | Phase 1 / Phase 2 | Completed | Otonomy, Inc. | 43 | 2019-04-04 | 2022-12-23 |
| Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo AUT00063, Placebo - Tinnitus, Subjective | Phase 2 | Completed | Autifony Therapeutics Limited | 91 | 2014-10-01 | 2016-03-31 |
| Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus Sulodexide, Placebo - Tinnitus, Subjective | Phase 2 | Completed | St Joseph University, Beirut, Lebanon | 126 | 2014-08-01 | 2017-09-14 |
Tinnitus (3)
Ear Diseases (3) · Hearing Disorders (3) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Otorhinolaryngologic Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Sensation Disorders (3) · Signs and Symptoms (3)
AUT00063 (1) · glucuronyl glucosamine glycan sulfate (1)
Autifony Therapeutics Limited (1) · Otonomy, Inc. (1) · St Joseph University, Beirut, Lebanon (1)
Lebanon (1) · United Kingdom (1) · United States (1)
Elias Eter, MD (1) · Jaydip Ray, MD (1)